Murli Krishna Pharma is making significant strides across more than 78 countries, serving over 200 customers worldwide. While we actively provide commercial supplies in many of these regions, several projects are currently in the pre-commercial phase, laying the groundwork for future growth.
Notably, we are expanding our footprint in the United States with multiple ongoing projects focused on 505(b)(2) applications and Abbreviated New Drug Applications (ANDAs). These initiatives demonstrate our commitment to navigating the complex regulatory landscape and our dedication to bringing innovative solutions to the U.S. market.
Our global presence, combined with our state-of-the-art manufacturing capabilities and relentless pursuit of quality, positions us to meet the diverse needs of our clients and adapt to evolving market demands. We look forward to continued growth and collaboration with our partners as we advance our projects in both established and emerging markets.
